CAI 0.00% 11.5¢ calidus resources limited

useless product, page-3

  1. 379 Posts.
    lightbulb Created with Sketch. 2
    As an oral tablet yes I agree

    As a gel there is minimal risk


    The Market has delivered it's verdict

    Also the PNO clinical trials are non existent

    If the product was any good a major pharma company would have done a joint venture

    I work in this area and let me say I have issues with the whole business model

 
watchlist Created with Sketch. Add CAI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.